Analyst Recommendations

BMO Capital analyst issues OUTPERFORM recommendation for TGB on April 9, 2024 11:00AM ET. The previous analyst recommendation was Outperform.TGB was trading at $2.52 at issue of the...

April 9, 2024   TGB -0.25%

Morgan Stanley analyst issues OVERWEIGHT recommendation for LVS on April 9, 2024 11:42AM ET. The previous analyst recommendation was Overweight.LVS was trading at $52.22 at issue of the...

April 9, 2024   LVS 1.25%

Needham analyst issues BUY recommendation for RXRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Buy.RXRX was trading at $9.165 at issue of the analyst...

April 9, 2024   RXRX 5.41%

RBC Capital analyst issues UNDERPERFORM recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Underperform.PCRX was trading at $28.44 at issue of the...

April 9, 2024   PCRX 0.37%

Wedbush analyst issues BUY recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Buy.PCRX was trading at $28.44 at issue of the analyst...

April 9, 2024   PCRX 0.37%

Susquehanna analyst issues BUY recommendation for BABA on April 9, 2024 10:01AM ET. The previous analyst recommendation was Buy.BABA was trading at $72.7012 at issue of the analyst...

April 9, 2024   BABA 1.63%

Piper Sandler analyst issues BUY recommendation for CUE on April 9, 2024 10:01AM ET. The previous analyst recommendation was Buy.CUE was trading at $1.9 at issue of the...

April 9, 2024   CUE 0.63%

Oppenheimer analyst issues UNDERPERFORM recommendation for CUE on April 9, 2024 10:01AM ET. The previous analyst recommendation was Underperform.CUE was trading at $1.9 at issue of the analyst...

April 9, 2024   CUE 0.63%

Wells Fargo analyst issues STRONG BUY recommendation for PR on April 9, 2024 10:01AM ET. The previous analyst recommendation was Strong Buy.PR was trading at $18.15 at issue...

April 9, 2024   PR -2.58%

Scotiabank analyst issues OUTPERFORM recommendation for CSCCF on April 9, 2024 08:51AM ET. The previous analyst recommendation was Outperform.CSCCF was trading at $6.75 at issue of the analyst...

April 9, 2024   CSCCF 0.74%